News Medical chatbot firm OpenEvidence raises $210m OpenEvidence has raised $210m to expand the capabilities of its physician decision-making tool and launch a new service offering 'PhD-level' research.
Sales & Marketing Sponsored Solution Spotlight: New .med URLs deliver value by indicatin... Currently in a period of pre-registration that runs through August 2025, .med is a secure, premium TLD for the medical sector.
Patients Health literacy matters: 3 ways to improve patient understan... Every day, thousands worldwide find out they have a disease or health condition that requires care.
Market Access HHS guidance on using online tracking technologies: How to m... In December 2022, the US Department of Health and Human Services (HHS) Office for Civil Rights (OCR) issued guidance on online tracking technology to HIPAA-covered entities.
Digital The optimal mix of AI and human interactions for healthcare ... Pharmaceutical firms all around the world are investing in AI technology alongside human experts to help provide satisfying HCP engagement experiences
Sales & Marketing Sponsored Informed patients: evolving healthcare, clinical trials and ... Overview Patients are more informed than ever about their conditions and what is available for them to improve their quality of life.
News Pulmonary fibrosis drug developer Avalyn files IPO Avalyn Pharma hops on the IPO train, filing to list on the Nasdaq and raise funds for late-stage trials of its inhaled pulmonary fibrosis therapies.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.